awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39111032-6386CE7E-805C-4F78-9AC8-5B757C2C9223
Q39111032-6386CE7E-805C-4F78-9AC8-5B757C2C9223
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39111032-6386CE7E-805C-4F78-9AC8-5B757C2C9223
JAK inhibitors in dermatology: The promise of a new drug class.
P2860
Q39111032-6386CE7E-805C-4F78-9AC8-5B757C2C9223
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39111032-6386CE7E-805C-4F78-9AC8-5B757C2C9223
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e94ec5a655145baafc545f14c28fcd475fd7afe9
P2860
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study.